Desmosomes in cardiomyocyte homeostasis and disease
桥粒在心肌细胞稳态和疾病中的作用
基本信息
- 批准号:10606894
- 负责人:
- 金额:$ 81.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-15 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAblationAccelerationAdhesivesAdipose tissueAdultArrhythmiaBiomedical EngineeringCardiacCardiac MyocytesCardiomyopathiesCell NucleusCellsChemicalsComplexDISC componentsDataDesmosomesDevelopmentDiseaseDissectionElementsExperimental ModelsFluorescent in Situ HybridizationFunctional disorderGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGoalsHeart AbnormalitiesHeart failureHomeostasisHumanIn Situ HybridizationIntercalated discKnowledgeLeadLifeLinkMetabolismMethodsModelingMolecularMusMuscle functionMutationMyocardial ContractionMyocardial dysfunctionMyocardiumN-CadherinPathogenesisPathway interactionsPatientsPeriodicityPhenotypePlasmaProteinsProteomicsRegulatory ElementRelaxationResolutionRoleSarcomeresSignal TransductionTestingVentricular ArrhythmiaWNT Signaling Pathwayarrhythmogenic cardiomyopathycandidate identificationcandidate selectiondefined contributiondesmoplakinfollow-upgain of functiongenetic approachheart rhythmimprovedin vivoinduced pluripotent stem cellinhibitorinnovationinsightloss of functionmosaicmultiple omicsmutantnovelpreservationprotein functionsingle moleculesingle nucleus RNA-sequencingtranscriptometranscriptomics
项目摘要
SUMMARY
Intercalated disks (ICDs) connect the termini of adjacent cardiomyocytes (CMs) physically, electrically, and
chemically. The structural role of ICDs to preserve CM integrity in the face of billions of cycles of forceful con-
traction and relaxation is well appreciated; however, the function of ICDs as essential CM signaling hubs is
only now emerging. Arrhythmogenic cardiomyopathy (ACM) provides a unique window into the function of
ICDs and specifically desmosomes. ACM is a potentially lethal disorder characterized by high arrhythmia bur-
den, loss of contractile myocardium, and replacement by fibro-fatty tissue. Mutations of desmosome genes
(PKP2, DSG2, DSC2, DSP, JUP) occur in approximately half of ACM patients. Despite growing knowledge
about ACM disease pathogenesis, the mechanistic links between desmosome mutations and arrhythmias, my-
ocardial dysfunction, and fibrofatty replacement remain poorly understood.
The overall goal of this proposal is to gain insights into the mechanisms by which desmosome mutations
cause arrhythmia and myocardial dysfunction; Our overarching hypothesis is that desmosomes are inte-
gral for maintaining normal cardiomyocyte homeostasis through both their structural and signaling
activities. ACM mutations disrupt these activities to cause both loss of structural integrity and aberrant
signaling. We will test these hypotheses through four parallel but complementary Specific Aims: (1) We will
examine cell composition and gene regulation of human ACM myocardium, using concurrent single nucleus
RNA-seq and ATAC-seq, and spatial transcriptomics (snMulti-seq) with massively parallel single molecule fluo-
rescent in situ hybridization (MERFISH); (2) We will use mosaic, adult, cardiomyocyte specific inactivation of
Dsp to probe the cell autonomous functions of desmosomes. This model will be studied using snMulti-seq and
MERFISH, followed by interrogation of key predicted regulators using in vivo gain- and loss-of-function ap-
proaches; (3) Using proximity proteomics of ICD component N-cadherin, we identified novel ICD components
and ICD components that are altered by Dsp ablation. We will use in vivo gain- and loss-of-function ap-
proaches to study the function of selected candidates identified by this screen; (4) Define the contributions of
WNT and GSK3 signaling to ACM phenotypes in DSP mutant hiPSC-CMs. Using genetic approaches in bioen-
gineered hiPSC-CMs, we will dissect the involvement of GSK3 and WNT signaling to ACM pathogenesis.
Impact: This proposal will advance our understanding of the function of desmosomes and ICDs in CM
homeostasis and the molecular pathogenesis of ACM. This knowledge will accelerate efforts to develop
targeted ACM therapies.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Tswenching Pu其他文献
William Tswenching Pu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Tswenching Pu', 18)}}的其他基金
CMYA5 regulation of cardiac dyad structure and function
CMYA5对心脏二元体结构和功能的调节
- 批准号:
10607816 - 财政年份:2022
- 资助金额:
$ 81.65万 - 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
- 批准号:
10576399 - 财政年份:2021
- 资助金额:
$ 81.65万 - 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
- 批准号:
10355481 - 财政年份:2021
- 资助金额:
$ 81.65万 - 项目类别:
Enabling mammalian in vivo forward genetic screens based on cell morphology
实现基于细胞形态的哺乳动物体内正向遗传筛选
- 批准号:
9754850 - 财政年份:2018
- 资助金额:
$ 81.65万 - 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
- 批准号:
9751955 - 财政年份:2017
- 资助金额:
$ 81.65万 - 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
- 批准号:
9376461 - 财政年份:2017
- 资助金额:
$ 81.65万 - 项目类别:
2015 Weinstein Cardiovaascular Development Conference
2015年韦恩斯坦心血管发展大会
- 批准号:
8911591 - 财政年份:2015
- 资助金额:
$ 81.65万 - 项目类别:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
YAP1 对心肌细胞增殖、功能和再生的调节
- 批准号:
8412652 - 财政年份:2013
- 资助金额:
$ 81.65万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 81.65万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 81.65万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 81.65万 - 项目类别:
Standard Grant














{{item.name}}会员




